Paper36364402
1,4-Naphthoquinone Motif in the Synthesis of New Thiopyrano[2,3-d]thiazoles as Potential Biologically Active Compounds.
Lozynskyi A and 15 others. Molecules, 2022. Cited by 8 papers, by iCite.
Cite this record
ConductScience Library. 1,4-Naphthoquinone Motif in the Synthesis of New Thiopyrano[2,3-d]thiazoles as Potential Biologically Active Compounds. Papers, record 36364402. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36364402
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- 1,4-Naphthoquinone Motif in the Synthesis of New Thiopyrano[2,3-d]thiazoles as Potential Biologically Active Compounds.
- PubMed
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Naphthoquinones | Major topic |
| Antineoplastic Agents | Major topic |
| Thiazoles | |
| Tumor Suppressor Protein p53 | |
| Drug Screening Assays, Antitumor |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 0121U100690 | Ministry of Health of Ukraine | PubMed | ||
| 2020.02/0035 | National Research Foundation of Ukraine | PubMed |
Source PubMed
References47
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 26133066 | Synthesis and anticancer activity of some new thiopyrano[2,3-d]thiazoles incorporating pyrazole moiety. | Chem Pharm Bull (Tokyo) | 2015 | https://conductscience.org/library/papers/26133066 | PubMed |
| 2 | 29358624 | Long-acting injectable atovaquone nanomedicines for malaria prophylaxis. | Nat Commun | 2018 | https://conductscience.org/library/papers/29358624 | PubMed |
| 3 | 30791399 | Vitamin K: Double Bonds beyond Coagulation Insights into Differences between Vitamin K1 and K2 in Health and Disease. | Int J Mol Sci | 2019 | https://conductscience.org/library/papers/30791399 | PubMed |
| 4 | 10891138 | Studies of Diastereoselectivity in Diels-Alder Reactions of Enantiopure (SS)-2-(p-Tolylsulfinyl)-1,4-naphthoquinone and Chiral Racemic Acyclic Dienes. | J Org Chem | 2000 | https://conductscience.org/library/papers/10891138 | PubMed |
| 5 | 7816645 | A rapid and simple method for the isolation of apoptotic DNA fragments. | Nucleic Acids Res | 1994 | https://conductscience.org/library/papers/7816645 | PubMed |
| 6 | 16469140 | Menadione is a metabolite of oral vitamin K. | Br J Nutr | 2006 | https://conductscience.org/library/papers/16469140 | PubMed |
| 7 | 10549580 | 2- or 6-(1-azidoalkyl)-5,8-dimethoxy-1,4-naphthoquinone: synthesis, evaluation of cytotoxic activity, antitumor activity and inhibitory effect on DNA topoisomerase-I. | Arch Pharm Res | 1999 | https://conductscience.org/library/papers/10549580 | PubMed |
| 8 | 35533562 | Novel hybrid pyrrolidinedione-thiazolidinones as potential anticancer agents: Synthesis and biological evaluation. | Eur J Med Chem | 2022 | https://conductscience.org/library/papers/35533562 | PubMed |
| 9 | 19171970 | Structure validation in chemical crystallography. | Acta Crystallogr D Biol Crystallogr | 2009 | https://conductscience.org/library/papers/19171970 | PubMed |
| 10 | 23833711 | Synthesis and Biological Activity of New Thiopyrano[2,3-d]thiazoles Containing a Naphthoquinone Moiety. | Sci Pharm | 2013 | https://conductscience.org/library/papers/23833711 | PubMed |
| 11 | 19505805 | Diospyrone, crassiflorone and plumbagin: three antimycobacterial and antigonorrhoeal naphthoquinones from two Diospyros spp. | Int J Antimicrob Agents | 2009 | https://conductscience.org/library/papers/19505805 | PubMed |
| 12 | 19924086 | The trypanocidal activity of naphthoquinones: a review. | Molecules | 2009 | https://conductscience.org/library/papers/19924086 | PubMed |
| 13 | 34771471 | New Therapeutic Strategy for Overcoming Multidrug Resistance in Cancer Cells with Pyrazolo[3,4-d]pyrimidine Tyrosine Kinase Inhibitors. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34771471 | PubMed |
| 14 | 29461185 | 1,4-Naphthoquinone derivatives potently suppress Candida albicans growth, inhibit formation of hyphae and show no toxicity toward zebrafish embryos. | J Med Microbiol | 2018 | https://conductscience.org/library/papers/29461185 | PubMed |
| 15 | 7785975 | Effect of atovaquone and atovaquone drug combinations on prophylaxis of Pneumocystis carinii pneumonia in SCID mice. | Antimicrob Agents Chemother | 1995 | https://conductscience.org/library/papers/7785975 | PubMed |
| 16 | 24666303 | 2-Chloro-1,4-naphthoquinone derivative of quercetin as an inhibitor of aldose reductase and anti-inflammatory agent. | J Enzyme Inhib Med Chem | 2015 | https://conductscience.org/library/papers/24666303 | PubMed |
| 17 | 31231607 | p53-Dependent Anti-Proliferative and Pro-Apoptotic Effects of a Gold(I) N-Heterocyclic Carbene (NHC) Complex in Colorectal Cancer Cells. | Front Oncol | 2019 | https://conductscience.org/library/papers/31231607 | PubMed |
| 18 | 23275348 | The naphthoquinone diospyrin is an inhibitor of DNA gyrase with a novel mechanism of action. | J Biol Chem | 2013 | https://conductscience.org/library/papers/23275348 | PubMed |
| 19 | 19559098 | A novel and simple method of screening compounds for interaction with DNA: A validation study. | Mutat Res | 2009 | https://conductscience.org/library/papers/19559098 | PubMed |
| 20 | 8416812 | Methyl green. A DNA major-groove binding drug. | FEBS Lett | 1993 | https://conductscience.org/library/papers/8416812 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41471376 | Molecular Hybridization of Naphthoquinones and Thiazoles: A Promising Strategy for Anticancer Drug Discovery. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/41471376 | PubMed |
| 39620933 | Characterization of naphthoquinones as inhibitors of glutathione reductase and inducers of intracellular oxidative stress. | Redox Rep | 2024 | https://conductscience.org/library/papers/39620933 | PubMed |
| 39297923 | 4-Methylthiazole triggers apoptosis and mitochondrial disruption in HL-60 cells. | Mol Biol Rep | 2024 | https://conductscience.org/library/papers/39297923 | PubMed |
Genes11
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ABCB1 | 5243 | PubTator's text mining | https://conductscience.org/library/genes/5243 | NCBI Gene |
| ABCC1 | 4363 | PubTator's text mining | https://conductscience.org/library/genes/4363 | NCBI Gene |
| AKR1B1 | 231 | PubTator's text mining | https://conductscience.org/library/genes/231 | NCBI Gene |
| BCRP1 | 644079 | PubTator's text mining | https://conductscience.org/library/genes/644079 | NCBI Gene |
| PGR | 5241 | PubTator's text mining | https://conductscience.org/library/genes/5241 | NCBI Gene |
| PIK3R1 | 5295 | PubTator's text mining | https://conductscience.org/library/genes/5295 | NCBI Gene |
| RNASE1 | 6035 | PubTator's text mining | https://conductscience.org/library/genes/6035 | NCBI Gene |
| RNF130 | 55819 | PubTator's text mining | https://conductscience.org/library/genes/55819 | NCBI Gene |
| STAT3 | 6774 | PubTator's text mining | https://conductscience.org/library/genes/6774 | NCBI Gene |
| TOP2A | 7153 | PubTator's text mining | https://conductscience.org/library/genes/7153 | NCBI Gene |
| TP53 | 7157 | PubTator's text mining | https://conductscience.org/library/genes/7157 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36364402
GET https://conductscience.org/api/papers/v1/36364402/references?page=2